{"gene":"HELLS","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2018,"finding":"HELLS and CDCA7 form a stoichiometric bipartite nucleosome remodeling complex on chromatin. HELLS alone fails to remodel nucleosomes, but the HELLS-CDCA7 complex possesses nucleosome remodeling activity. CDCA7 is essential for loading HELLS onto chromatin, and ICF patient mutations in CDCA7 fail to recruit the complex to chromatin. Complex formation is sensitive to Aurora B kinase.","method":"Xenopus egg extract chromatin proteomics, reconstitution of nucleosome remodeling activity in vitro, chromatin fractionation, ICF mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of remodeling activity, multiple orthogonal methods (proteomics, chromatin fractionation, mutant analysis), mechanistically definitive","pmids":["29339483"],"is_preprint":false},{"year":2018,"finding":"CDCA7 and HELLS interact with C-NHEJ proteins Ku80 and Ku70 (co-immunoprecipitation). CDCA7- and HELLS-deficient cells show compromised classical non-homologous end joining activity and significant delay in Ku80 accumulation at DNA damage sites, leading to increased apoptosis, abnormal chromosome segregation, aneuploidy, centrosome amplification, and γH2AX accumulation.","method":"Co-immunoprecipitation, CRISPR/siRNA knockdown in HEK293 cells, live-cell imaging of Ku80 recruitment, γH2AX immunofluorescence, chromosomal break repair assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple cellular assays with defined phenotypic readouts, validated in patient lymphoblastoid cells","pmids":["30307408"],"is_preprint":false},{"year":2020,"finding":"HELLS promotes homologous recombination repair of two-ended DSBs by facilitating end-resection; HELLS interacts with CtIP and promotes CtIP accumulation at IR-induced foci. The ATPase domain of HELLS is required for this DSB repair function. HELLS also contributes to DSB repair within heterochromatic regions during G2.","method":"Co-immunoprecipitation (HELLS-CtIP interaction), siRNA knockdown, immunofluorescence for IR-induced foci, ATPase domain mutant analysis, cell-cycle staged assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ATPase domain mutagenesis, multiple orthogonal assays in single study","pmids":["31802118"],"is_preprint":false},{"year":2020,"finding":"HELLS is recruited to meiotic recombination hot spots by PRDM9 and forms a pioneer complex with PRDM9. HELLS is necessary for histone modifications and DNA accessibility at hot spots. In male mice lacking HELLS, DSBs are retargeted to other open chromatin sites, leading to germ cell death and sterility.","method":"Mouse knockout, ChIP-seq, ATAC-seq, DSB mapping, immunofluorescence","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — mouse knockout with defined meiotic phenotype, ChIP-seq and ATAC-seq for chromatin accessibility, multiple orthogonal readouts","pmids":["32001511"],"is_preprint":false},{"year":2020,"finding":"HELLS is required for PRDM9 binding and DSB activity at PRDM9-specified meiotic hot spots (but not at PRDM9-independent sites). HELLS is identified as a PRDM9 interacting partner by proteomics. HELLS is also essential for 5-hydroxymethylcytosine (5hmC) enrichment at PRDM9 sites, which is triggered upon PRDM9 binding and histone modification independently of DSB activity.","method":"Proteomic identification of PRDM9 partners, mouse knockout, ChIP-seq, 5hmC mapping, DSB activity assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteomic identification plus mouse knockout with multiple orthogonal epigenomic readouts","pmids":["33047671"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of human HELLS reveals it assembles into a hexameric (trimer-of-dimers) architecture in its apo (autoinhibited) state, stabilized by interactions between the N-terminal coiled-coil (CC) domain and ATPase Lobe-1, with ATPase Lobe-2 remaining flexible and disengaged. The CC domain functions as both an oligomerization scaffold and an autoinhibitory module. Binding of CDCA7 and DNA promotes formation of an active HELLS-CDCA7-DNA ternary complex, with CDCA7 stimulating HELLS ATPase activity by recognizing hemimethylated CpG dinucleotides.","method":"Cryo-EM structure determination, biochemical ATPase assays, biophysical binding assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure combined with biochemical activity assays, published in peer-reviewed journal","pmids":["41954988"],"is_preprint":false},{"year":2023,"finding":"The zf-4CXXC_R1 domain of CDCA7 selectively binds hemimethylated CpG DNA (not unmethylated or fully methylated CpG) and recruits HELLS to hemimethylated DNA via N-terminal alpha-helix interactions. Cryo-EM of the CDCA7-nucleosome complex shows zf-4CXXC_R1 recognizes hemimethylated CpG in the major groove at linker DNA. ICF disease mutations in the zinc finger domain eliminate hemimethylated DNA binding and HELLS recruitment.","method":"Cryo-EM, in vitro DNA binding assays, mutagenesis of ICF mutations, reconstitution of HELLS-CDCA7 complex","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with in vitro binding assays and ICF mutant validation, multiple orthogonal methods","pmids":["38187757"],"is_preprint":true},{"year":2024,"finding":"The central region of CDCA7 is critical for binding to HELLS, activation of HELLS ATPase activity, and nucleosome sliding activity. The N-terminal region of CDCA7 tends to inhibit ATPase activity. The C-terminal 4CXXC-type zinc finger domain of CDCA7 confers preference for hemimethylated CpG DNA in HELLS-CDCA7 ATPase activity. CDCA7 shows binding preference for hemimethylated CpG DNA and recruits HELLS to hemimethylated replication sites at pericentromeric heterochromatin in mouse ES cells; ICF syndrome zinc finger mutations abolish these activities.","method":"In vitro ATPase assays with CDCA7 domain mutants, nucleosome sliding assay, DNA binding assays, immunofluorescence in mouse ES cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with domain mutagenesis, multiple functional assays, ICF mutant validation","pmids":["39142653"],"is_preprint":false},{"year":2004,"finding":"Disruption of PASG/HELLS (SNF2-like factor) causes global DNA hypomethylation, developmental growth retardation, and premature aging phenotype in mice. PASG mutant fibroblasts show replicative senescence with increased p16(INK4a) expression associated with down-regulation of bmi-1. PASG is essential for maintaining DNA methylation and gene expression patterns required for normal growth and longevity.","method":"Mouse knockout (PASG/LSH null), bisulfite sequencing for DNA methylation, qRT-PCR, primary fibroblast senescence assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — mouse knockout with defined molecular and cellular phenotypes, multiple orthogonal readouts","pmids":["15105378"],"is_preprint":false},{"year":2011,"finding":"HELLS interacts with E2F3A in vivo and cooperates with its oncogenic functions. Depletion of HELLS perturbs induction of E2F-target genes and hinders cell-cycle re-entry and growth. ChIP-seq identifies HELLS binding at promoters of active genes including MLL1, co-regulating E2F3-dependent genes.","method":"Mass spectrometry identification of E2F3B partners, co-immunoprecipitation, ChIP-seq, siRNA knockdown, cell cycle analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — MS identification followed by Co-IP validation, genome-wide ChIP-seq, siRNA with defined proliferative phenotype","pmids":["22157815"],"is_preprint":false},{"year":2020,"finding":"HELLS-CDCA7 complex is required for accumulation of maintenance DNA methylation machinery (DNMT1/UHRF1) on nascent DNA. CDCA7/HELLS-deficient cells show increased transcription and aberrant DNA:RNA hybrid (R-loop) formation at pericentromeric repeats. Ectopic RNASEH1 expression reduced DNA damage accumulation in ICF mutant cells, indicating the CDCA7/HELLS complex suppresses R-loop-associated DNA damage at pericentromeric repeats.","method":"Nascent DNA proteomics (iPOND-like), R-loop detection, RNASEH1 rescue experiment, bisulfite sequencing","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple assays in single lab; rescue experiment provides pathway evidence","pmids":["33082427"],"is_preprint":false},{"year":2015,"finding":"ATPase-deficient HELLS is retained at the nuclear matrix compartment (defined in part by lamin B1) and shows stronger association with heterochromatin. Wild-type HELLS is highly dynamic at heterochromatic sites (FRAP t1/2 = 0.8s, 61% mobile fraction), while ATPase-deficient HELLS shows reduced dynamics (t1/2 = 4.5s, 30% mobile). ATPase activity is not required for recruitment to heterochromatin but is important for release from these sites. H3K9me3 signaling contributes to efficient release of HELLS from pericentromeric chromatin.","method":"Chromatin fractionation, FRAP (fluorescence recovery after photobleaching), immunofluorescence microscopy, ATPase domain mutagenesis","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ATPase mutagenesis with quantitative FRAP measurements and chromatin fractionation, multiple methods in single study","pmids":["25823553"],"is_preprint":false},{"year":2021,"finding":"TET proteins interact with HELLS/LSH in vivo and in vitro. Knockout of Lsh in mouse embryonic fibroblasts and embryonic stem cells leads to significant reduction in 5-hydroxymethylcytosine (5hmC) genome-wide. Changes in 5hmC distribution in Lsh knockout cells do not completely overlap with differentially methylated regions, suggesting HELLS regulation of 5hmC is not solely a consequence of 5mC decrease.","method":"Co-immunoprecipitation (TET-HELLS), Lsh knockout mouse cells, whole-genome 5hmC sequencing (oxBS-seq), bisulfite sequencing","journal":"Epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus knockout with genome-wide sequencing, single lab","pmids":["33960278"],"is_preprint":false},{"year":2011,"finding":"HELLS is essential for meiotic progression in male mice. In the absence of HELLS, spermatogonial proliferation is reduced and germ cell differentiation arrests at the midpachytene stage, with increased abnormal chromosome synapsis, indicating an essential role for HELLS during male meiosis.","method":"Testis tissue allografting from Hells-/- mice to immunodeficient hosts, BrdU incorporation, cytological analysis of meiotic configurations","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined meiotic arrest phenotype, single lab","pmids":["21349825"],"is_preprint":false},{"year":2020,"finding":"LSH/HELLS is enriched at meiotic kinetochores and its deletion causes centromere instability, abnormal chromosome segregation, ectopic kinetochore formation, and centromere fusions in oocyte meiosis. LSH knockout oocytes show increased histone H3 phosphorylation at threonine 3 (H3T3ph) and accumulation of major satellite transcripts. LSH knockout reduces HDAC2 and DNMT1 at kinetochores.","method":"Conditional oocyte-specific Lsh knockout, super-resolution microscopy, immunofluorescence, chromosome spreads","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with super-resolution imaging, multiple epigenomic readouts, defined mechanistic pathway","pmids":["32900989"],"is_preprint":false},{"year":2020,"finding":"HELLS is required for B cell development and immunoglobulin class switch recombination (CSR). Lsh-deficient B cells proliferate normally but show impaired canonical end-joining (C-NHEJ) during CSR, as demonstrated by digestion-circularization PCR and high-throughput sequencing of CSR junctions. The initiation of recombination (germline transcripts, AID-induced DSBs) is unaffected by Lsh loss.","method":"Conditional Lsh knockout mouse (Mx1-Cre, Vav-Cre), bone marrow transplantation, B cell in vitro stimulation, End-seq, biotin-labeling DSB assay, digestion-circularization PCR, high-throughput CSR junction sequencing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout, multiple orthogonal sequencing approaches, defined mechanistic epistasis showing NHEJ defect","pmids":["32727902"],"is_preprint":false},{"year":2019,"finding":"HELLS overexpression in hepatocellular carcinoma increases nucleosome occupancy, obstructs enhancer accessibility, and hinders formation of nucleosome-free regions at transcription start sites, leading to epigenetic silencing of multiple tumor suppressor genes including E-cadherin, FBP1, IGFBP3, XAF1 and CREB3L3. HELLS upregulation in HCC is mediated by hyperactivation of transcription factor SP1.","method":"CRISPR activation, lentiviral shRNA, CRISPR/Cas9 knockout, RNA-seq, micrococcal nuclease sequencing (MNase-seq), ChIP, in vivo xenograft models","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — integrated RNA-seq and MNase-seq with gain and loss of function, in vivo validation","pmids":["30516846"],"is_preprint":false},{"year":2000,"finding":"HELLS/PASG encodes a SNF2 family chromatin remodeling ATPase whose nuclear localization depends on a nuclear localization sequence in the N-terminal region. Expression is associated with cell proliferation. An in-frame 75-nucleotide deletion found in AML/ALL removes a conserved motif critical for transactivation activity of a related yeast SWI/SNF polypeptide.","method":"cDNA sequence analysis, expression studies, nuclear localization sequence mapping by deletion analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct NLS mapping by deletion, sequence-based motif identification, multiple cancer samples","pmids":["10910076"],"is_preprint":false},{"year":2017,"finding":"Lsh/HELLS ablation in neural stem/progenitor cells (NSPCs) reduces growth, increases apoptosis, and impairs self-renewal. Lsh deletion alters epigenetic states (assessed by ChIP) at specific enhancer regions of Cdkn1a (p21) and Bmp4, and alters their expression.","method":"Lsh-/- conditional neural stem cell model, RNA-seq, ChIP at enhancer regions, proliferation and apoptosis assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout with defined cellular phenotype and ChIP evidence of enhancer regulation, single lab","pmids":["28442710"],"is_preprint":false},{"year":2019,"finding":"HELLS interacts with the core oncogenic transcription factors E2F3 and MYC in glioblastoma stem cells (GSCs) to regulate gene expression critical to GSC proliferation and maintenance. Targeting HELLS disrupts GSC proliferation, survival, and self-renewal with induction of replication stress and DNA damage.","method":"Co-immunoprecipitation (HELLS with E2F3 and MYC), siRNA/shRNA knockdown, proliferation/sphere formation assays, in vivo tumor-bearing mouse model","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP for interaction, siRNA knockdown with phenotype, in vivo validation, single lab","pmids":["30779712"],"is_preprint":false},{"year":2021,"finding":"HELLS, together with transcription factor YY1, regulates cytokinesis in ALK- ALCL cells by transcriptional activation of cytoskeleton genes including RhoA, RhoU, and Pak2. HELLS binds target promoters and primes YY1 recruitment and transcriptional activation. RhoA and RhoU mediate HELLS effects on cell proliferation and division.","method":"RNA-seq, ChIP, bioinformatic prediction, siRNA knockdown of HELLS/YY1/RhoA/RhoU/Pak2, cell proliferation/division assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for promoter binding, epistasis via multiple knockdowns, single lab","pmids":["33504766"],"is_preprint":false},{"year":2024,"finding":"HELLS reduces the persistence of co-transcriptional R-loops and promotes RNA Polymerase II (RNAPII) progression along gene bodies in ALCL cells, loading at intronic regions of target gene promoters. HELLS knockdown sensitizes ALCL cells to chemotherapeutic agents.","method":"Multi-omics (ChIP-seq, DRIP-seq for R-loops, RNA-seq), RNAPII ChIP-seq, HELLS siRNA knockdown, drug sensitivity assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-omics integration, single lab, defined molecular mechanism for RNAPII progression","pmids":["38597676"],"is_preprint":false},{"year":2017,"finding":"The S. cerevisiae HELLS homolog Irc5 interacts with the cohesin complex subunit Scc1 and contributes to cohesin binding to chromatin. Loss of IRC5 decreases cohesin levels at centromeres and chromosome arms, causing premature sister chromatid separation. Irc5 translocase activity is required for its function in cohesion. Irc5 loss also reduces chromatin-bound Scc2 (cohesin loader) levels and the Scc1-Scc2 physical interaction.","method":"Co-immunoprecipitation (Irc5-Scc1), ChIP (cohesin at centromeres/arms), chromosome segregation assays, ATPase mutant analysis, rDNA repeat stability","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP, ATPase mutant, defined yeast ortholog with conserved function; yeast model","pmids":["28383696"],"is_preprint":false},{"year":2025,"finding":"HELLS loss impairs single-strand break (SSB) repair and selectively sensitizes cells to DNA alkylating agents and PARP inhibitors. HELLS shows non-epistatic interactions with PARP1 and functionally compensates for PARP1 deficiency in promoting cell survival in response to DNA alkylation damage. HELLS loss is synthetic lethal with homologous recombination deficiency.","method":"HELLS knockout/knockdown, SSB repair assays, drug sensitivity assays (alkylating agents, PARPi), epistasis analysis with PARP1","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined DNA repair assay, epistasis with PARP1, peer-reviewed publication","pmids":["41297801"],"is_preprint":false},{"year":2023,"finding":"HELLS is required for germinal center (GC) B cell maintenance and generation of high-affinity memory B cells. B-cell-specific Hells knockout leads to dramatic DNA hypomethylation and de-repression of retrotransposons in GC B cells, and premature upregulation of memory B cell or plasma cell markers. DNMT1-specific inhibition phenocopies accelerated GC decay, indicating that DNA-methylation maintenance by HELLS is the key mechanism fine-tuning the GC transcriptional program.","method":"B-cell-specific conditional Hells knockout, DNMT1 inhibitor treatment, bisulfite sequencing, RNA-seq, retrotransposon analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with DNMT1 inhibitor phenocopy, multiple sequencing approaches, defined mechanistic pathway","pmids":["37709749"],"is_preprint":false},{"year":2025,"finding":"HELLS directly regulates MIEF1 (Mitochondrial elongation factor 1) transcription in liver cancer. HELLS knockdown causes mitochondrial hyperfusion, energy deprivation, and cellular senescence. HELLS knockdown globally increases H3K9me3 with upregulation of SUV39H1 and augmented DNA methylation. The HELLS-MIEF1 axis links nuclear chromatin remodeling to mitochondrial dynamics.","method":"HELLS loss/gain experiments, MIEF1 ChIP, RNA-seq, mitochondrial morphology/function assays, H3K9me3 ChIP, siRNA epistasis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct target, epistasis rescue, mitochondrial functional assays, single lab","pmids":["40175344"],"is_preprint":false},{"year":2025,"finding":"HELLS knockdown in HELLS-deficient cells leads to loss of tumor capabilities in osteoclast differentiation context. HELLS directly represses Nr2f2 transcription (demonstrated by ChIP-qPCR and FAIRE-qPCR showing HELLS binding and chromatin accessibility changes at Nr2f2 promoter). Nr2f2 suppression by HELLS maintains mitochondrial quality through coordinated regulation of biogenesis and mitophagy during osteoclast differentiation.","method":"RNA-seq, ChIP-qPCR, FAIRE-qPCR, siRNA knockdown of Hells and Nr2f2, Nr2f2 inhibitor rescue, mitochondrial function assays","journal":"Cell communication and signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP evidence of direct binding at Nr2f2, epistasis rescue with Nr2f2 inhibitor, single lab","pmids":["41947194"],"is_preprint":false},{"year":2025,"finding":"HELLS binds and resolves G-quadruplex (G4) DNA structures in vitro and in chromatin. HELLS-G4 interaction modulates gene expression. Identified as a G4-binding protein via photoclick chemistry-based proteomics using G4 DNA probes from human telomeric sequences.","method":"Photoclick chemistry-LC-MS/MS proteomics, fluorescence anisotropy, FRET-based G4 unwinding assay, immunofluorescence microscopy, ChIP-seq","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro biochemical G4 binding/unwinding plus ChIP-seq, multiple orthogonal methods, single lab","pmids":["41569154"],"is_preprint":false},{"year":2025,"finding":"USP1 interacts with and stabilizes HELLS through deubiquitination, preventing ubiquitin-mediated degradation. USP1 also promotes HELLS SUMOylation by stabilizing the E3 SUMO ligase PIAS1 through deubiquitination. The USP1/PIAS1/HELLS axis drives EMT and homologous recombination repair in HCC cells.","method":"Co-immunoprecipitation (USP1-HELLS), ubiquitination/SUMOylation assays, functional assays in HCC cells, in vivo xenograft, USP1 inhibitor (ML323) treatment","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for interaction, direct biochemical ubiquitination/SUMOylation assays, in vivo validation, single lab","pmids":["41430042"],"is_preprint":false},{"year":2025,"finding":"HELLS knockout in human pluripotent stem cells induces a global loss of DNA methylation that is most prominent over peri/centromeric satellite repeats (as defined by the telomere-to-telomere genome assembly), but HELLS appears dispensable for local enhancer remodeling and differentiation into the three embryonic germ layers.","method":"HELLS and DNMT3A/B knockout in human pluripotent stem cells, whole-genome bisulfite sequencing, ATAC-seq, differentiation assays","journal":"Genome biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with genome-wide bisulfite + ATAC-seq, T2T assembly annotation, functional differentiation assays","pmids":["40676590"],"is_preprint":false},{"year":2025,"finding":"HELLS alone assembles into a hexameric (trimer-of-dimers) autoinhibited state in its apo form (cryo-EM structure), with the N-terminal coiled-coil (CC) domain stabilizing interactions with ATPase Lobe-1 while Lobe-2 is disengaged. CDCA7 binding and DNA (particularly hemimethylated CpG) promote formation of an active ternary complex and stimulate HELLS ATPase activity.","method":"Cryo-EM, ATPase assays, biophysical binding assays (preprint version)","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — cryo-EM structure with biochemical validation but preprint; superseded by peer-reviewed version (PMID 41954988)","pmids":["41669160"],"is_preprint":true},{"year":2025,"finding":"ZBTB24, CDCA7 and HELLS function as negative regulators of 2C-like reprogramming in mouse ESCs by maintaining DNA methylation of the Dux cluster. Disruption of HELLS results in Dux hypomethylation and derepression, leading to upregulation of 2C-specific genes. Site-specific re-methylation at the Dux promoter reverses this phenotype. CDCA7 is enriched at the Dux cluster and recruits the CDCA7-HELLS complex to constitutive heterochromatin.","method":"CRISPR knockout of ZBTB24/CDCA7/HELLS in mESCs, bisulfite sequencing, ChIP, dCas9-based targeted methylation rescue, single-cell RNA-seq","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with mechanistic rescue by targeted re-methylation, ChIP for complex recruitment, multiple orthogonal approaches","pmids":["40226918"],"is_preprint":false}],"current_model":"HELLS is an SNF2-family ATP-dependent chromatin remodeler that, in its apo form, adopts an autoinhibited hexameric architecture; it is activated into a catalytically competent nucleosome remodeling complex upon binding CDCA7, which senses hemimethylated CpG DNA through its zf-4CXXC_R1 domain and recruits HELLS to replication sites, enabling maintenance DNA methylation at heterochromatin and pericentromeric repeats. Beyond DNA methylation maintenance, HELLS participates in multiple DNA repair pathways (homologous recombination via CtIP, classical NHEJ via Ku70/Ku80, and single-strand break repair), regulates meiotic recombination hot spot activation together with PRDM9, controls gene transcription as a co-activator of E2F3 and MYC, suppresses R-loop accumulation to facilitate RNAPII elongation, and can bind and resolve G-quadruplex structures; its loss causes ICF syndrome through combined defects in DNA methylation and DNA repair."},"narrative":{"mechanistic_narrative":"HELLS is an SNF2-family ATP-dependent chromatin remodeling ATPase that maintains DNA methylation at heterochromatin and pericentromeric/satellite repeats and supports multiple genome-stability pathways [PMID:15105378, PMID:40676590]. In its apo state HELLS self-assembles into an autoinhibited hexamer (trimer-of-dimers) in which the N-terminal coiled-coil domain serves as both an oligomerization scaffold and an autoinhibitory module engaging ATPase Lobe-1 [PMID:41954988]. HELLS alone cannot remodel nucleosomes; it is activated by CDCA7, which recognizes hemimethylated CpG DNA through its zf-4CXXC_R1 zinc-finger domain, loads HELLS onto chromatin at replication sites, and stimulates HELLS ATPase and nucleosome-sliding activity to form a catalytically competent ternary remodeling complex [PMID:29339483, PMID:41954988, PMID:38187757, PMID:39142653]. This CDCA7–HELLS complex enables accumulation of the maintenance methylation machinery (DNMT1/UHRF1) on nascent DNA and is recruited to constitutive heterochromatin to silence repeats such as the Dux cluster; ICF-syndrome zinc-finger mutations in CDCA7 abolish hemimethylated-DNA binding and HELLS recruitment [PMID:39142653, PMID:33082427, PMID:40226918]. ATPase activity is dispensable for heterochromatin recruitment but required for release from pericentromeric sites, a step coupled to H3K9me3 [PMID:25823553]. Beyond methylation maintenance, HELLS promotes DNA double-strand break repair by facilitating CtIP-dependent end resection in homologous recombination and by interacting with Ku70/Ku80 to support classical NHEJ, including immunoglobulin class-switch recombination, and contributes to single-strand break repair with synthetic-lethal relationships to PARP1 and HR deficiency [PMID:30307408, PMID:31802118, PMID:32727902, PMID:41297801]. HELLS is also recruited by PRDM9 to meiotic recombination hot spots, where it establishes chromatin accessibility and is required for hot-spot DSB activity and meiotic progression [PMID:32001511, PMID:33047671, PMID:21349825]. As a transcriptional regulator it partners with E2F3 and MYC and binds active promoters to drive proliferative gene programs, and its overexpression in hepatocellular carcinoma remodels nucleosomes to silence tumor-suppressor genes [PMID:22157815, PMID:30516846, PMID:30779712]. HELLS loss causes global DNA hypomethylation with premature aging and senescence phenotypes in mice [PMID:15105378].","teleology":[{"year":2000,"claim":"Established HELLS/PASG as a proliferation-associated SNF2-family chromatin remodeling ATPase with a defined N-terminal nuclear localization sequence, anchoring it to the SWI/SNF remodeler class.","evidence":"cDNA and sequence analysis with deletion mapping of the NLS, expression studies in leukemia samples","pmids":["10910076"],"confidence":"Medium","gaps":["No direct demonstration of nucleosome remodeling activity","No interacting partners or substrate specificity defined"]},{"year":2004,"claim":"Defined the core in vivo role of HELLS by showing its loss causes global DNA hypomethylation linked to growth retardation, premature aging, and replicative senescence.","evidence":"PASG/LSH-null mouse knockout with bisulfite sequencing and primary fibroblast senescence assays","pmids":["15105378"],"confidence":"High","gaps":["Did not establish whether HELLS acts directly on methylation machinery or via remodeling","Recruitment mechanism to target loci unknown"]},{"year":2011,"claim":"Connected HELLS to oncogenic transcription by showing it interacts with E2F3A and is required for induction of E2F-target genes and cell-cycle re-entry, expanding its role beyond methylation.","evidence":"Mass spectrometry, Co-IP, ChIP-seq, and siRNA knockdown with cell-cycle analysis","pmids":["22157815"],"confidence":"High","gaps":["Whether transcriptional co-activation requires ATPase/remodeling activity not resolved","Direct vs indirect promoter effects not separated"]},{"year":2011,"claim":"Demonstrated HELLS is essential for male meiotic progression, foreshadowing a chromatin role at meiotic loci.","evidence":"Hells-/- testis allografting with cytological analysis of meiotic synapsis","pmids":["21349825"],"confidence":"Medium","gaps":["Molecular target loci of HELLS in meiosis not identified","Mechanism of arrest at midpachytene unknown at the time"]},{"year":2015,"claim":"Distinguished recruitment from catalysis by showing ATPase activity is not needed for heterochromatin targeting but is required for HELLS release, with H3K9me3 coupling enzymatic turnover to chromatin dynamics.","evidence":"ATPase-domain mutagenesis with quantitative FRAP and chromatin fractionation","pmids":["25823553"],"confidence":"High","gaps":["Factor mediating initial recruitment not identified","Link between release and methylation maintenance not yet mechanistic"]},{"year":2018,"claim":"Resolved the recruitment problem by identifying CDCA7 as the obligate partner that loads HELLS onto chromatin and reconstitutes nucleosome remodeling, with ICF mutations failing to recruit the complex.","evidence":"Xenopus egg extract chromatin proteomics, in vitro remodeling reconstitution, chromatin fractionation, ICF mutant analysis","pmids":["29339483"],"confidence":"High","gaps":["Structural basis of HELLS activation by CDCA7 not yet defined","Role of Aurora B sensitivity in regulation unclear"]},{"year":2018,"claim":"Extended HELLS function into genome maintenance by showing HELLS and CDCA7 interact with Ku70/Ku80 and are required for classical NHEJ, with loss producing genome instability.","evidence":"Reciprocal Co-IP, knockdown in HEK293, live imaging of Ku80 recruitment, chromosomal break repair assays in patient cells","pmids":["30307408"],"confidence":"High","gaps":["Whether remodeling activity is required for NHEJ support not tested","Direct vs scaffolding role at break sites unresolved"]},{"year":2020,"claim":"Showed HELLS also promotes homologous recombination by facilitating CtIP-dependent end resection, requiring its ATPase domain, especially in heterochromatic DSB repair.","evidence":"Co-IP with CtIP, IR-induced foci immunofluorescence, ATPase mutant analysis, cell-cycle staged assays","pmids":["31802118"],"confidence":"High","gaps":["How HELLS choice between HR and NHEJ pathways is regulated unknown","Mechanism linking remodeling to resection not detailed"]},{"year":2020,"claim":"Defined HELLS as a PRDM9 pioneer-complex partner required for chromatin accessibility, histone modification, and DSB targeting at meiotic recombination hot spots.","evidence":"Mouse knockout, proteomic identification of PRDM9 partners, ChIP-seq, ATAC-seq, 5hmC and DSB mapping","pmids":["32001511","33047671"],"confidence":"High","gaps":["How PRDM9 directs HELLS independently of CDCA7-hemimethyl recognition unclear","Relationship between hot-spot 5hmC and DSB formation not fully mechanistic"]},{"year":2020,"claim":"Linked HELLS-CDCA7 remodeling to maintenance methylation machinery loading and to suppression of pericentromeric R-loop-associated damage.","evidence":"Nascent-DNA proteomics, R-loop detection, RNASEH1 rescue, bisulfite sequencing","pmids":["33082427"],"confidence":"Medium","gaps":["Single-lab; direct causality between R-loop suppression and methylation maintenance not separated","No structural mechanism for DNMT1/UHRF1 recruitment"]},{"year":2020,"claim":"Demonstrated HELLS supports classical NHEJ during immunoglobulin class-switch recombination, with the defect downstream of break initiation.","evidence":"Conditional Lsh knockout B cells, End-seq, digestion-circularization PCR, high-throughput CSR junction sequencing","pmids":["32727902"],"confidence":"High","gaps":["Whether the CSR defect reflects methylation maintenance or direct end-joining support not fully separated"]},{"year":2020,"claim":"Revealed a centromeric integrity role in oocyte meiosis, with LSH at kinetochores retaining HDAC2/DNMT1 and restraining satellite transcription.","evidence":"Oocyte-specific conditional knockout, super-resolution microscopy, immunofluorescence, chromosome spreads","pmids":["32900989"],"confidence":"High","gaps":["Direct mechanism of kinetochore targeting unknown","Relationship to CDCA7-dependent recruitment not tested"]},{"year":2021,"claim":"Implicated HELLS in 5hmC homeostasis through TET interaction, with effects not fully explained by 5mC loss.","evidence":"Co-IP with TET, Lsh knockout cells, genome-wide oxBS 5hmC sequencing","pmids":["33960278"],"confidence":"Medium","gaps":["Single lab; whether HELLS directly facilitates TET activity not established","Functional consequence of 5hmC redistribution unclear"]},{"year":2023,"claim":"Provided the structural mechanism of targeting by showing CDCA7's zf-4CXXC_R1 domain selectively reads hemimethylated CpG in linker DNA and recruits HELLS, with ICF mutations abolishing this.","evidence":"Cryo-EM of CDCA7-nucleosome complex, in vitro DNA binding, ICF mutant analysis (preprint)","pmids":["38187757"],"confidence":"High","gaps":["Preprint at time of capture","How recognition couples to HELLS catalytic activation not fully resolved here"]},{"year":2024,"claim":"Mapped CDCA7 domains controlling HELLS binding and activation, showing the central region activates ATPase/sliding while the C-terminal zinc finger confers hemimethyl-CpG preference.","evidence":"In vitro ATPase and nucleosome sliding assays with CDCA7 domain mutants, DNA binding, mES cell immunofluorescence","pmids":["39142653"],"confidence":"High","gaps":["Conformational changes in HELLS upon activation not visualized in this study","Regulation of CDCA7 autoinhibition in vivo unknown"]},{"year":2025,"claim":"Solved the autoinhibited HELLS hexamer by cryo-EM, revealing the coiled-coil domain as both oligomerization scaffold and autoinhibitory module released upon CDCA7/DNA binding to form an active ternary complex.","evidence":"Cryo-EM structure with ATPase and biophysical binding assays (peer-reviewed and preprint versions)","pmids":["41954988","41669160"],"confidence":"High","gaps":["Structure of the fully engaged remodeling complex on a nucleosome not resolved","How oligomeric state changes during catalysis unclear"]},{"year":2025,"claim":"Established HELLS as a single-strand break repair factor with synthetic-lethal vulnerabilities, compensating for PARP1 and sensitizing HR-deficient cells.","evidence":"HELLS knockout/knockdown, SSB repair assays, alkylator/PARPi sensitivity, PARP1 epistasis","pmids":["41297801"],"confidence":"Medium","gaps":["Molecular mechanism of HELLS in SSBR not defined","Single lab; direct enzymatic role versus chromatin context not separated"]},{"year":2025,"claim":"Refined the methylation-maintenance role by showing HELLS-dependent methylation is concentrated at peri/centromeric satellites yet dispensable for enhancer remodeling and germ-layer differentiation.","evidence":"HELLS and DNMT3A/B knockouts in human pluripotent stem cells, whole-genome bisulfite, ATAC-seq, differentiation assays with T2T annotation","pmids":["40676590"],"confidence":"High","gaps":["Why some loci are HELLS-independent not mechanistically explained"]},{"year":2025,"claim":"Showed the ZBTB24-CDCA7-HELLS axis silences the Dux cluster to restrain 2C-like reprogramming, with targeted re-methylation rescuing the phenotype.","evidence":"CRISPR knockouts in mESCs, bisulfite sequencing, ChIP, dCas9-targeted methylation rescue, scRNA-seq","pmids":["40226918"],"confidence":"High","gaps":["How ZBTB24 integrates with CDCA7-hemimethyl recognition not detailed"]},{"year":2025,"claim":"Identified HELLS as a G-quadruplex binding and unwinding protein that modulates gene expression, adding a structured-DNA resolution activity.","evidence":"Photoclick proteomics, fluorescence anisotropy, FRET unwinding assays, ChIP-seq","pmids":["41569154"],"confidence":"Medium","gaps":["Single lab; relationship of G4 resolution to remodeling/methylation roles unclear","In vivo physiological significance not established"]},{"year":2025,"claim":"Connected HELLS chromatin function to broader transcriptional and metabolic outputs in cancer through R-loop suppression and direct target gene regulation.","evidence":"Multi-omics ChIP/DRIP/RNA-seq, RNAPII ChIP-seq, ChIP-qPCR/FAIRE, mitochondrial assays, and stability regulation via USP1 in HCC/ALCL contexts","pmids":["38597676","33504766","30779712","30516846","40175344","41947194","41430042","28442710"],"confidence":"Medium","gaps":["Many context-specific targets from single labs","Whether effects depend on remodeling versus scaffolding not consistently tested"]},{"year":null,"claim":"How HELLS partitions among its many roles — maintenance methylation, HR/NHEJ/SSB repair, meiotic hot-spot priming, G4 resolution, and transcriptional regulation — and how the CDCA7-dependent activation switch is selectively deployed at each remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model coordinating recruitment cues across pathways","Structure of the active HELLS-CDCA7 complex engaged on a nucleosome unresolved","Whether non-methylation roles require the same activation mechanism unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,2,5,7,11]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,27]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[9,16,19,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[17]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[11,14,29,31]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,8,29,31]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,2,15,23]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[3,4,13,14]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,16,21]}],"complexes":["HELLS-CDCA7 nucleosome remodeling complex","PRDM9 meiotic pioneer complex"],"partners":["CDCA7","PRDM9","CTIP","KU70","KU80","E2F3","MYC","TET"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NRZ9","full_name":"Lymphoid-specific helicase","aliases":["Proliferation-associated SNF2-like protein","SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6","SMARCA6"],"length_aa":838,"mass_kda":97.1,"function":"ATP-dependent chromatin remodeler that regulates chromatin accessibility, DNA methylation, and histone modifications. It facilitates de novo DNA methylation at repetitive sequences and promotes transcriptional silencing via recruitment of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), contributing to heterochromatin formation and repression of transposable elements (PubMed:30307408). Also involved in DNA repair by recruiting DNA damage response mediators to double-strand breaks in heterochromatin, promoting homologous recombination via RBBP8/CtIP-dependent end resection (PubMed:22946062, PubMed:31802118). During meiosis, it is recruited by PRDM9 to recombination hotspots, aiding chromatin opening (PubMed:32001511). Through these diverse roles, is crucial for processes such as development, differentiation, and genomic stability (PubMed:22946062, PubMed:31802118). Involved in regulation of the expansion or survival of lymphoid cells (By similarity)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9NRZ9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HELLS","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"NUMA1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HELLS","total_profiled":1310},"omim":[{"mim_id":"620059","title":"LONG INTERGENIC NONCODING RNA 472; LINC00472","url":"https://www.omim.org/entry/620059"},{"mim_id":"616911","title":"IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4","url":"https://www.omim.org/entry/616911"},{"mim_id":"616910","title":"IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3","url":"https://www.omim.org/entry/616910"},{"mim_id":"609937","title":"CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7; CDCA7","url":"https://www.omim.org/entry/609937"},{"mim_id":"603946","title":"HELICASE, LYMPHOID-SPECIFIC; HELLS","url":"https://www.omim.org/entry/603946"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":10.5}],"url":"https://www.proteinatlas.org/search/HELLS"},"hgnc":{"alias_symbol":["PASG","SMARCA6","LSH","Nbla10143","SALNR"],"prev_symbol":[]},"alphafold":{"accession":"Q9NRZ9","domains":[{"cath_id":"3.40.50.10810","chopping":"244-417","consensus_level":"high","plddt":85.3444,"start":244,"end":417},{"cath_id":"3.40.50.300","chopping":"464-472_601-814","consensus_level":"medium","plddt":79.5109,"start":464,"end":814},{"cath_id":"1.20.5","chopping":"66-92","consensus_level":"medium","plddt":55.0493,"start":66,"end":92}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRZ9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRZ9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NRZ9-F1-predicted_aligned_error_v6.png","plddt_mean":68.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HELLS","jax_strain_url":"https://www.jax.org/strain/search?query=HELLS"},"sequence":{"accession":"Q9NRZ9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NRZ9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NRZ9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NRZ9"}},"corpus_meta":[{"pmid":"26216346","id":"PMC_26216346","title":"Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26216346","citation_count":151,"is_preprint":false},{"pmid":"15105378","id":"PMC_15105378","title":"Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15105378","citation_count":143,"is_preprint":false},{"pmid":"29339483","id":"PMC_29339483","title":"HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29339483","citation_count":109,"is_preprint":false},{"pmid":"20400365","id":"PMC_20400365","title":"Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.","date":"2010","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20400365","citation_count":80,"is_preprint":false},{"pmid":"30307408","id":"PMC_30307408","title":"CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30307408","citation_count":75,"is_preprint":false},{"pmid":"22157815","id":"PMC_22157815","title":"The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22157815","citation_count":70,"is_preprint":false},{"pmid":"10910076","id":"PMC_10910076","title":"Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10910076","citation_count":66,"is_preprint":false},{"pmid":"29659838","id":"PMC_29659838","title":"Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29659838","citation_count":64,"is_preprint":false},{"pmid":"30516846","id":"PMC_30516846","title":"HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma.","date":"2019","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/30516846","citation_count":60,"is_preprint":false},{"pmid":"32001511","id":"PMC_32001511","title":"HELLS and PRDM9 form a pioneer complex to open chromatin at meiotic recombination hot spots.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/32001511","citation_count":53,"is_preprint":false},{"pmid":"31802118","id":"PMC_31802118","title":"The human HELLS chromatin remodelling protein promotes end resection to facilitate homologous recombination and contributes to DSB repair within heterochromatin.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31802118","citation_count":50,"is_preprint":false},{"pmid":"30779712","id":"PMC_30779712","title":"Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30779712","citation_count":42,"is_preprint":false},{"pmid":"26491010","id":"PMC_26491010","title":"Senescence-associated Long Non-coding RNA (SALNR) Delays Oncogene-induced Senescence through NF90 Regulation.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26491010","citation_count":38,"is_preprint":false},{"pmid":"33082427","id":"PMC_33082427","title":"CDCA7 and HELLS suppress DNA:RNA hybrid-associated DNA damage at pericentromeric repeats.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33082427","citation_count":34,"is_preprint":false},{"pmid":"28442710","id":"PMC_28442710","title":"Lsh/HELLS regulates self-renewal/proliferation of neural stem/progenitor cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28442710","citation_count":34,"is_preprint":false},{"pmid":"25338120","id":"PMC_25338120","title":"Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25338120","citation_count":33,"is_preprint":false},{"pmid":"32071286","id":"PMC_32071286","title":"Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression.","date":"2020","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32071286","citation_count":31,"is_preprint":false},{"pmid":"21349825","id":"PMC_21349825","title":"Lymphoid-specific helicase (HELLS) is essential for meiotic progression in mouse spermatocytes.","date":"2011","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21349825","citation_count":31,"is_preprint":false},{"pmid":"15305370","id":"PMC_15305370","title":"Tumor-specific exon creation of the HELLS/SMARCA6 gene in non-small cell lung cancer.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15305370","citation_count":28,"is_preprint":false},{"pmid":"33280236","id":"PMC_33280236","title":"HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33280236","citation_count":28,"is_preprint":false},{"pmid":"21925500","id":"PMC_21925500","title":"Hell's Gate globin I: an acid and thermostable bacterial hemoglobin resembling mammalian neuroglobin.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21925500","citation_count":28,"is_preprint":false},{"pmid":"32727902","id":"PMC_32727902","title":"Lsh/HELLS is required for B lymphocyte development and immunoglobulin class switch recombination.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32727902","citation_count":27,"is_preprint":false},{"pmid":"36012581","id":"PMC_36012581","title":"The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36012581","citation_count":26,"is_preprint":false},{"pmid":"33047671","id":"PMC_33047671","title":"PRDM9 activity depends on HELLS and promotes local 5-hydroxymethylcytosine enrichment.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33047671","citation_count":24,"is_preprint":false},{"pmid":"32195055","id":"PMC_32195055","title":"Identification and validation of HELLS (Helicase, Lymphoid-Specific) and ICAM1 (Intercellular adhesion molecule 1) as potential diagnostic biomarkers of lung cancer.","date":"2020","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/32195055","citation_count":24,"is_preprint":false},{"pmid":"32063710","id":"PMC_32063710","title":"Downregulation of the Helicase Lymphoid-Specific (HELLS) Gene Impairs Cell Proliferation and Induces Cell Cycle Arrest in Colorectal Cancer Cells.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32063710","citation_count":24,"is_preprint":false},{"pmid":"30094095","id":"PMC_30094095","title":"Aryl hydrocarbon receptor activated by benzo (a) pyrene promotes SMARCA6 expression in NSCLC.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30094095","citation_count":22,"is_preprint":false},{"pmid":"22109759","id":"PMC_22109759","title":"Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma.","date":"2011","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/22109759","citation_count":22,"is_preprint":false},{"pmid":"31541170","id":"PMC_31541170","title":"Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31541170","citation_count":20,"is_preprint":false},{"pmid":"32900989","id":"PMC_32900989","title":"Helicase LSH/Hells regulates kinetochore function, histone H3/Thr3 phosphorylation and centromere transcription during oocyte meiosis.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32900989","citation_count":19,"is_preprint":false},{"pmid":"37769127","id":"PMC_37769127","title":"Coevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37769127","citation_count":18,"is_preprint":false},{"pmid":"39142653","id":"PMC_39142653","title":"The C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/39142653","citation_count":17,"is_preprint":false},{"pmid":"28383696","id":"PMC_28383696","title":"The LSH/HELLS homolog Irc5 contributes to cohesin association with chromatin in yeast.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28383696","citation_count":17,"is_preprint":false},{"pmid":"37709749","id":"PMC_37709749","title":"Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37709749","citation_count":15,"is_preprint":false},{"pmid":"25823553","id":"PMC_25823553","title":"An ATPase-deficient variant of the SNF2 family member HELLS shows altered dynamics at pericentromeric heterochromatin.","date":"2015","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25823553","citation_count":14,"is_preprint":false},{"pmid":"33504766","id":"PMC_33504766","title":"The DNA-helicase HELLS drives ALK- ALCL proliferation by the transcriptional control of a cytokinesis-related program.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33504766","citation_count":13,"is_preprint":false},{"pmid":"32123306","id":"PMC_32123306","title":"The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS.","date":"2020","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/32123306","citation_count":13,"is_preprint":false},{"pmid":"30220967","id":"PMC_30220967","title":"Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30220967","citation_count":13,"is_preprint":false},{"pmid":"33791206","id":"PMC_33791206","title":"MiR-365a-3p-Mediated Regulation of HELLS/GLUT1 Axis Suppresses Aerobic Glycolysis and Gastric Cancer Growth.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33791206","citation_count":13,"is_preprint":false},{"pmid":"15611660","id":"PMC_15611660","title":"Altered epigenetic patterning leading to replicative senescence and reduced longevity. A role of a novel SNF2 factor, PASG.","date":"2005","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/15611660","citation_count":12,"is_preprint":false},{"pmid":"35053620","id":"PMC_35053620","title":"HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35053620","citation_count":10,"is_preprint":false},{"pmid":"18948754","id":"PMC_18948754","title":"Stable knockdown of PASG enhances DNA demethylation but does not accelerate cellular senescence in TIG-7 human fibroblasts.","date":"2008","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18948754","citation_count":9,"is_preprint":false},{"pmid":"38597676","id":"PMC_38597676","title":"HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38597676","citation_count":7,"is_preprint":false},{"pmid":"33960278","id":"PMC_33960278","title":"The chromatin remodelling protein LSH/HELLS regulates the amount and distribution of DNA hydroxymethylation in the genome.","date":"2021","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/33960278","citation_count":7,"is_preprint":false},{"pmid":"33460027","id":"PMC_33460027","title":"Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC.","date":"2021","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33460027","citation_count":6,"is_preprint":false},{"pmid":"37920816","id":"PMC_37920816","title":"HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype.","date":"2023","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/37920816","citation_count":6,"is_preprint":false},{"pmid":"40226918","id":"PMC_40226918","title":"The ZBTB24-CDCA7-HELLS axis suppresses the totipotent 2C-like reprogramming by maintaining Dux methylation and repression.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/40226918","citation_count":4,"is_preprint":false},{"pmid":"36194437","id":"PMC_36194437","title":"Chromatin remodelers HELLS, WDHD1 and BAZ1A are dynamically expressed during mouse spermatogenesis.","date":"2022","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36194437","citation_count":4,"is_preprint":false},{"pmid":"40175344","id":"PMC_40175344","title":"HELLS controls mitochondrial dynamics and genome stability in liver cancer by collusion with MIEF1.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40175344","citation_count":3,"is_preprint":false},{"pmid":"38187757","id":"PMC_38187757","title":"CDCA7 is a hemimethylated DNA adaptor for the nucleosome remodeler HELLS.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38187757","citation_count":3,"is_preprint":false},{"pmid":"35311456","id":"PMC_35311456","title":"Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35311456","citation_count":3,"is_preprint":false},{"pmid":"41669160","id":"PMC_41669160","title":"Structure of human lymphoid-specific helicase HELLS in its autoinhibitory state.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41669160","citation_count":3,"is_preprint":false},{"pmid":"39890476","id":"PMC_39890476","title":"HELLS: the transcriptional sentinel.","date":"2025","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39890476","citation_count":2,"is_preprint":false},{"pmid":"41297801","id":"PMC_41297801","title":"The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage.","date":"2025","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41297801","citation_count":2,"is_preprint":false},{"pmid":"39763743","id":"PMC_39763743","title":"Chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39763743","citation_count":2,"is_preprint":false},{"pmid":"38478260","id":"PMC_38478260","title":"HELLS Knockdown Inhibits the Malignant Progression of Lung Adenocarcinoma Via Blocking Akt/CREB Pathway by Downregulating KIF11.","date":"2024","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38478260","citation_count":2,"is_preprint":false},{"pmid":"37252915","id":"PMC_37252915","title":"Lost in HELLS: Disentangling the mystery of SALNR existence in senescence cellular models.","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/37252915","citation_count":1,"is_preprint":false},{"pmid":"36778482","id":"PMC_36778482","title":"Coevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36778482","citation_count":1,"is_preprint":false},{"pmid":"41430042","id":"PMC_41430042","title":"Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance.","date":"2025","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/41430042","citation_count":1,"is_preprint":false},{"pmid":"41823538","id":"PMC_41823538","title":"HELLS inhibits autophagy‑dependent ferroptosis in nasopharyngeal carcinoma by modulating the Nrf2/HO‑1/GPX4 pathway.","date":"2026","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41823538","citation_count":1,"is_preprint":false},{"pmid":"41569154","id":"PMC_41569154","title":"Photoclick chemistry led to the identification of HELLS as a helicase for DNA G-quadruplexes.","date":"2026","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41569154","citation_count":1,"is_preprint":false},{"pmid":"39179495","id":"PMC_39179495","title":"Oxidative modulations in platelets stored in SSP+, PAS-G and Tyrode's buffer: a comparative analysis.","date":"2024","source":"Hematology, transfusion and cell therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39179495","citation_count":1,"is_preprint":false},{"pmid":"23377896","id":"PMC_23377896","title":"Molecular dynamics study of hell's gate globin I (HGbI) from a methanotrophic extremophile: oxygen migration through a large cavity.","date":"2013","source":"Journal of molecular modeling","url":"https://pubmed.ncbi.nlm.nih.gov/23377896","citation_count":1,"is_preprint":false},{"pmid":"40676590","id":"PMC_40676590","title":"HELLS is required for maintaining proper DNA modification at human satellite repeats.","date":"2025","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/40676590","citation_count":0,"is_preprint":false},{"pmid":"41947194","id":"PMC_41947194","title":"Hells protects mitochondrial integrity via Nr2f2 suppression during osteoclast differentiation.","date":"2026","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/41947194","citation_count":0,"is_preprint":false},{"pmid":"41954988","id":"PMC_41954988","title":"Structure of human lymphoid-specific helicase HELLS in its autoinhibited state.","date":"2026","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41954988","citation_count":0,"is_preprint":false},{"pmid":"42065057","id":"PMC_42065057","title":"CDCA7 Promotes Proliferation and Suppresses Apoptosis in Gastric Cancer via HELLS-Mediated Chromatin Remodeling.","date":"2026","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/42065057","citation_count":0,"is_preprint":false},{"pmid":"42196517","id":"PMC_42196517","title":"HELLS Reduction Contributes to Compressive Force-Induced Functional Changes in PDLSCs.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/42196517","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.26.620424","title":"In-depth investigation of genome to refine QTL positions for spontaneous sex-reversal in XX rainbow trout","date":"2024-10-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.26.620424","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":33978,"output_tokens":8478,"usd":0.114552,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18371,"output_tokens":6333,"usd":0.12509,"stage2_stop_reason":"end_turn"},"total_usd":0.239642,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"HELLS and CDCA7 form a stoichiometric bipartite nucleosome remodeling complex on chromatin. HELLS alone fails to remodel nucleosomes, but the HELLS-CDCA7 complex possesses nucleosome remodeling activity. CDCA7 is essential for loading HELLS onto chromatin, and ICF patient mutations in CDCA7 fail to recruit the complex to chromatin. Complex formation is sensitive to Aurora B kinase.\",\n      \"method\": \"Xenopus egg extract chromatin proteomics, reconstitution of nucleosome remodeling activity in vitro, chromatin fractionation, ICF mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of remodeling activity, multiple orthogonal methods (proteomics, chromatin fractionation, mutant analysis), mechanistically definitive\",\n      \"pmids\": [\"29339483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CDCA7 and HELLS interact with C-NHEJ proteins Ku80 and Ku70 (co-immunoprecipitation). CDCA7- and HELLS-deficient cells show compromised classical non-homologous end joining activity and significant delay in Ku80 accumulation at DNA damage sites, leading to increased apoptosis, abnormal chromosome segregation, aneuploidy, centrosome amplification, and γH2AX accumulation.\",\n      \"method\": \"Co-immunoprecipitation, CRISPR/siRNA knockdown in HEK293 cells, live-cell imaging of Ku80 recruitment, γH2AX immunofluorescence, chromosomal break repair assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple cellular assays with defined phenotypic readouts, validated in patient lymphoblastoid cells\",\n      \"pmids\": [\"30307408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HELLS promotes homologous recombination repair of two-ended DSBs by facilitating end-resection; HELLS interacts with CtIP and promotes CtIP accumulation at IR-induced foci. The ATPase domain of HELLS is required for this DSB repair function. HELLS also contributes to DSB repair within heterochromatic regions during G2.\",\n      \"method\": \"Co-immunoprecipitation (HELLS-CtIP interaction), siRNA knockdown, immunofluorescence for IR-induced foci, ATPase domain mutant analysis, cell-cycle staged assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ATPase domain mutagenesis, multiple orthogonal assays in single study\",\n      \"pmids\": [\"31802118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HELLS is recruited to meiotic recombination hot spots by PRDM9 and forms a pioneer complex with PRDM9. HELLS is necessary for histone modifications and DNA accessibility at hot spots. In male mice lacking HELLS, DSBs are retargeted to other open chromatin sites, leading to germ cell death and sterility.\",\n      \"method\": \"Mouse knockout, ChIP-seq, ATAC-seq, DSB mapping, immunofluorescence\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mouse knockout with defined meiotic phenotype, ChIP-seq and ATAC-seq for chromatin accessibility, multiple orthogonal readouts\",\n      \"pmids\": [\"32001511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HELLS is required for PRDM9 binding and DSB activity at PRDM9-specified meiotic hot spots (but not at PRDM9-independent sites). HELLS is identified as a PRDM9 interacting partner by proteomics. HELLS is also essential for 5-hydroxymethylcytosine (5hmC) enrichment at PRDM9 sites, which is triggered upon PRDM9 binding and histone modification independently of DSB activity.\",\n      \"method\": \"Proteomic identification of PRDM9 partners, mouse knockout, ChIP-seq, 5hmC mapping, DSB activity assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteomic identification plus mouse knockout with multiple orthogonal epigenomic readouts\",\n      \"pmids\": [\"33047671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of human HELLS reveals it assembles into a hexameric (trimer-of-dimers) architecture in its apo (autoinhibited) state, stabilized by interactions between the N-terminal coiled-coil (CC) domain and ATPase Lobe-1, with ATPase Lobe-2 remaining flexible and disengaged. The CC domain functions as both an oligomerization scaffold and an autoinhibitory module. Binding of CDCA7 and DNA promotes formation of an active HELLS-CDCA7-DNA ternary complex, with CDCA7 stimulating HELLS ATPase activity by recognizing hemimethylated CpG dinucleotides.\",\n      \"method\": \"Cryo-EM structure determination, biochemical ATPase assays, biophysical binding assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure combined with biochemical activity assays, published in peer-reviewed journal\",\n      \"pmids\": [\"41954988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The zf-4CXXC_R1 domain of CDCA7 selectively binds hemimethylated CpG DNA (not unmethylated or fully methylated CpG) and recruits HELLS to hemimethylated DNA via N-terminal alpha-helix interactions. Cryo-EM of the CDCA7-nucleosome complex shows zf-4CXXC_R1 recognizes hemimethylated CpG in the major groove at linker DNA. ICF disease mutations in the zinc finger domain eliminate hemimethylated DNA binding and HELLS recruitment.\",\n      \"method\": \"Cryo-EM, in vitro DNA binding assays, mutagenesis of ICF mutations, reconstitution of HELLS-CDCA7 complex\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with in vitro binding assays and ICF mutant validation, multiple orthogonal methods\",\n      \"pmids\": [\"38187757\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The central region of CDCA7 is critical for binding to HELLS, activation of HELLS ATPase activity, and nucleosome sliding activity. The N-terminal region of CDCA7 tends to inhibit ATPase activity. The C-terminal 4CXXC-type zinc finger domain of CDCA7 confers preference for hemimethylated CpG DNA in HELLS-CDCA7 ATPase activity. CDCA7 shows binding preference for hemimethylated CpG DNA and recruits HELLS to hemimethylated replication sites at pericentromeric heterochromatin in mouse ES cells; ICF syndrome zinc finger mutations abolish these activities.\",\n      \"method\": \"In vitro ATPase assays with CDCA7 domain mutants, nucleosome sliding assay, DNA binding assays, immunofluorescence in mouse ES cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with domain mutagenesis, multiple functional assays, ICF mutant validation\",\n      \"pmids\": [\"39142653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Disruption of PASG/HELLS (SNF2-like factor) causes global DNA hypomethylation, developmental growth retardation, and premature aging phenotype in mice. PASG mutant fibroblasts show replicative senescence with increased p16(INK4a) expression associated with down-regulation of bmi-1. PASG is essential for maintaining DNA methylation and gene expression patterns required for normal growth and longevity.\",\n      \"method\": \"Mouse knockout (PASG/LSH null), bisulfite sequencing for DNA methylation, qRT-PCR, primary fibroblast senescence assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mouse knockout with defined molecular and cellular phenotypes, multiple orthogonal readouts\",\n      \"pmids\": [\"15105378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HELLS interacts with E2F3A in vivo and cooperates with its oncogenic functions. Depletion of HELLS perturbs induction of E2F-target genes and hinders cell-cycle re-entry and growth. ChIP-seq identifies HELLS binding at promoters of active genes including MLL1, co-regulating E2F3-dependent genes.\",\n      \"method\": \"Mass spectrometry identification of E2F3B partners, co-immunoprecipitation, ChIP-seq, siRNA knockdown, cell cycle analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS identification followed by Co-IP validation, genome-wide ChIP-seq, siRNA with defined proliferative phenotype\",\n      \"pmids\": [\"22157815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HELLS-CDCA7 complex is required for accumulation of maintenance DNA methylation machinery (DNMT1/UHRF1) on nascent DNA. CDCA7/HELLS-deficient cells show increased transcription and aberrant DNA:RNA hybrid (R-loop) formation at pericentromeric repeats. Ectopic RNASEH1 expression reduced DNA damage accumulation in ICF mutant cells, indicating the CDCA7/HELLS complex suppresses R-loop-associated DNA damage at pericentromeric repeats.\",\n      \"method\": \"Nascent DNA proteomics (iPOND-like), R-loop detection, RNASEH1 rescue experiment, bisulfite sequencing\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple assays in single lab; rescue experiment provides pathway evidence\",\n      \"pmids\": [\"33082427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ATPase-deficient HELLS is retained at the nuclear matrix compartment (defined in part by lamin B1) and shows stronger association with heterochromatin. Wild-type HELLS is highly dynamic at heterochromatic sites (FRAP t1/2 = 0.8s, 61% mobile fraction), while ATPase-deficient HELLS shows reduced dynamics (t1/2 = 4.5s, 30% mobile). ATPase activity is not required for recruitment to heterochromatin but is important for release from these sites. H3K9me3 signaling contributes to efficient release of HELLS from pericentromeric chromatin.\",\n      \"method\": \"Chromatin fractionation, FRAP (fluorescence recovery after photobleaching), immunofluorescence microscopy, ATPase domain mutagenesis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ATPase mutagenesis with quantitative FRAP measurements and chromatin fractionation, multiple methods in single study\",\n      \"pmids\": [\"25823553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TET proteins interact with HELLS/LSH in vivo and in vitro. Knockout of Lsh in mouse embryonic fibroblasts and embryonic stem cells leads to significant reduction in 5-hydroxymethylcytosine (5hmC) genome-wide. Changes in 5hmC distribution in Lsh knockout cells do not completely overlap with differentially methylated regions, suggesting HELLS regulation of 5hmC is not solely a consequence of 5mC decrease.\",\n      \"method\": \"Co-immunoprecipitation (TET-HELLS), Lsh knockout mouse cells, whole-genome 5hmC sequencing (oxBS-seq), bisulfite sequencing\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus knockout with genome-wide sequencing, single lab\",\n      \"pmids\": [\"33960278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HELLS is essential for meiotic progression in male mice. In the absence of HELLS, spermatogonial proliferation is reduced and germ cell differentiation arrests at the midpachytene stage, with increased abnormal chromosome synapsis, indicating an essential role for HELLS during male meiosis.\",\n      \"method\": \"Testis tissue allografting from Hells-/- mice to immunodeficient hosts, BrdU incorporation, cytological analysis of meiotic configurations\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined meiotic arrest phenotype, single lab\",\n      \"pmids\": [\"21349825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LSH/HELLS is enriched at meiotic kinetochores and its deletion causes centromere instability, abnormal chromosome segregation, ectopic kinetochore formation, and centromere fusions in oocyte meiosis. LSH knockout oocytes show increased histone H3 phosphorylation at threonine 3 (H3T3ph) and accumulation of major satellite transcripts. LSH knockout reduces HDAC2 and DNMT1 at kinetochores.\",\n      \"method\": \"Conditional oocyte-specific Lsh knockout, super-resolution microscopy, immunofluorescence, chromosome spreads\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with super-resolution imaging, multiple epigenomic readouts, defined mechanistic pathway\",\n      \"pmids\": [\"32900989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HELLS is required for B cell development and immunoglobulin class switch recombination (CSR). Lsh-deficient B cells proliferate normally but show impaired canonical end-joining (C-NHEJ) during CSR, as demonstrated by digestion-circularization PCR and high-throughput sequencing of CSR junctions. The initiation of recombination (germline transcripts, AID-induced DSBs) is unaffected by Lsh loss.\",\n      \"method\": \"Conditional Lsh knockout mouse (Mx1-Cre, Vav-Cre), bone marrow transplantation, B cell in vitro stimulation, End-seq, biotin-labeling DSB assay, digestion-circularization PCR, high-throughput CSR junction sequencing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout, multiple orthogonal sequencing approaches, defined mechanistic epistasis showing NHEJ defect\",\n      \"pmids\": [\"32727902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HELLS overexpression in hepatocellular carcinoma increases nucleosome occupancy, obstructs enhancer accessibility, and hinders formation of nucleosome-free regions at transcription start sites, leading to epigenetic silencing of multiple tumor suppressor genes including E-cadherin, FBP1, IGFBP3, XAF1 and CREB3L3. HELLS upregulation in HCC is mediated by hyperactivation of transcription factor SP1.\",\n      \"method\": \"CRISPR activation, lentiviral shRNA, CRISPR/Cas9 knockout, RNA-seq, micrococcal nuclease sequencing (MNase-seq), ChIP, in vivo xenograft models\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — integrated RNA-seq and MNase-seq with gain and loss of function, in vivo validation\",\n      \"pmids\": [\"30516846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HELLS/PASG encodes a SNF2 family chromatin remodeling ATPase whose nuclear localization depends on a nuclear localization sequence in the N-terminal region. Expression is associated with cell proliferation. An in-frame 75-nucleotide deletion found in AML/ALL removes a conserved motif critical for transactivation activity of a related yeast SWI/SNF polypeptide.\",\n      \"method\": \"cDNA sequence analysis, expression studies, nuclear localization sequence mapping by deletion analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct NLS mapping by deletion, sequence-based motif identification, multiple cancer samples\",\n      \"pmids\": [\"10910076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Lsh/HELLS ablation in neural stem/progenitor cells (NSPCs) reduces growth, increases apoptosis, and impairs self-renewal. Lsh deletion alters epigenetic states (assessed by ChIP) at specific enhancer regions of Cdkn1a (p21) and Bmp4, and alters their expression.\",\n      \"method\": \"Lsh-/- conditional neural stem cell model, RNA-seq, ChIP at enhancer regions, proliferation and apoptosis assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with defined cellular phenotype and ChIP evidence of enhancer regulation, single lab\",\n      \"pmids\": [\"28442710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HELLS interacts with the core oncogenic transcription factors E2F3 and MYC in glioblastoma stem cells (GSCs) to regulate gene expression critical to GSC proliferation and maintenance. Targeting HELLS disrupts GSC proliferation, survival, and self-renewal with induction of replication stress and DNA damage.\",\n      \"method\": \"Co-immunoprecipitation (HELLS with E2F3 and MYC), siRNA/shRNA knockdown, proliferation/sphere formation assays, in vivo tumor-bearing mouse model\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP for interaction, siRNA knockdown with phenotype, in vivo validation, single lab\",\n      \"pmids\": [\"30779712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HELLS, together with transcription factor YY1, regulates cytokinesis in ALK- ALCL cells by transcriptional activation of cytoskeleton genes including RhoA, RhoU, and Pak2. HELLS binds target promoters and primes YY1 recruitment and transcriptional activation. RhoA and RhoU mediate HELLS effects on cell proliferation and division.\",\n      \"method\": \"RNA-seq, ChIP, bioinformatic prediction, siRNA knockdown of HELLS/YY1/RhoA/RhoU/Pak2, cell proliferation/division assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for promoter binding, epistasis via multiple knockdowns, single lab\",\n      \"pmids\": [\"33504766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HELLS reduces the persistence of co-transcriptional R-loops and promotes RNA Polymerase II (RNAPII) progression along gene bodies in ALCL cells, loading at intronic regions of target gene promoters. HELLS knockdown sensitizes ALCL cells to chemotherapeutic agents.\",\n      \"method\": \"Multi-omics (ChIP-seq, DRIP-seq for R-loops, RNA-seq), RNAPII ChIP-seq, HELLS siRNA knockdown, drug sensitivity assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-omics integration, single lab, defined molecular mechanism for RNAPII progression\",\n      \"pmids\": [\"38597676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The S. cerevisiae HELLS homolog Irc5 interacts with the cohesin complex subunit Scc1 and contributes to cohesin binding to chromatin. Loss of IRC5 decreases cohesin levels at centromeres and chromosome arms, causing premature sister chromatid separation. Irc5 translocase activity is required for its function in cohesion. Irc5 loss also reduces chromatin-bound Scc2 (cohesin loader) levels and the Scc1-Scc2 physical interaction.\",\n      \"method\": \"Co-immunoprecipitation (Irc5-Scc1), ChIP (cohesin at centromeres/arms), chromosome segregation assays, ATPase mutant analysis, rDNA repeat stability\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP, ATPase mutant, defined yeast ortholog with conserved function; yeast model\",\n      \"pmids\": [\"28383696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS loss impairs single-strand break (SSB) repair and selectively sensitizes cells to DNA alkylating agents and PARP inhibitors. HELLS shows non-epistatic interactions with PARP1 and functionally compensates for PARP1 deficiency in promoting cell survival in response to DNA alkylation damage. HELLS loss is synthetic lethal with homologous recombination deficiency.\",\n      \"method\": \"HELLS knockout/knockdown, SSB repair assays, drug sensitivity assays (alkylating agents, PARPi), epistasis analysis with PARP1\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined DNA repair assay, epistasis with PARP1, peer-reviewed publication\",\n      \"pmids\": [\"41297801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HELLS is required for germinal center (GC) B cell maintenance and generation of high-affinity memory B cells. B-cell-specific Hells knockout leads to dramatic DNA hypomethylation and de-repression of retrotransposons in GC B cells, and premature upregulation of memory B cell or plasma cell markers. DNMT1-specific inhibition phenocopies accelerated GC decay, indicating that DNA-methylation maintenance by HELLS is the key mechanism fine-tuning the GC transcriptional program.\",\n      \"method\": \"B-cell-specific conditional Hells knockout, DNMT1 inhibitor treatment, bisulfite sequencing, RNA-seq, retrotransposon analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with DNMT1 inhibitor phenocopy, multiple sequencing approaches, defined mechanistic pathway\",\n      \"pmids\": [\"37709749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS directly regulates MIEF1 (Mitochondrial elongation factor 1) transcription in liver cancer. HELLS knockdown causes mitochondrial hyperfusion, energy deprivation, and cellular senescence. HELLS knockdown globally increases H3K9me3 with upregulation of SUV39H1 and augmented DNA methylation. The HELLS-MIEF1 axis links nuclear chromatin remodeling to mitochondrial dynamics.\",\n      \"method\": \"HELLS loss/gain experiments, MIEF1 ChIP, RNA-seq, mitochondrial morphology/function assays, H3K9me3 ChIP, siRNA epistasis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct target, epistasis rescue, mitochondrial functional assays, single lab\",\n      \"pmids\": [\"40175344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS knockdown in HELLS-deficient cells leads to loss of tumor capabilities in osteoclast differentiation context. HELLS directly represses Nr2f2 transcription (demonstrated by ChIP-qPCR and FAIRE-qPCR showing HELLS binding and chromatin accessibility changes at Nr2f2 promoter). Nr2f2 suppression by HELLS maintains mitochondrial quality through coordinated regulation of biogenesis and mitophagy during osteoclast differentiation.\",\n      \"method\": \"RNA-seq, ChIP-qPCR, FAIRE-qPCR, siRNA knockdown of Hells and Nr2f2, Nr2f2 inhibitor rescue, mitochondrial function assays\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP evidence of direct binding at Nr2f2, epistasis rescue with Nr2f2 inhibitor, single lab\",\n      \"pmids\": [\"41947194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS binds and resolves G-quadruplex (G4) DNA structures in vitro and in chromatin. HELLS-G4 interaction modulates gene expression. Identified as a G4-binding protein via photoclick chemistry-based proteomics using G4 DNA probes from human telomeric sequences.\",\n      \"method\": \"Photoclick chemistry-LC-MS/MS proteomics, fluorescence anisotropy, FRET-based G4 unwinding assay, immunofluorescence microscopy, ChIP-seq\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro biochemical G4 binding/unwinding plus ChIP-seq, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"41569154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"USP1 interacts with and stabilizes HELLS through deubiquitination, preventing ubiquitin-mediated degradation. USP1 also promotes HELLS SUMOylation by stabilizing the E3 SUMO ligase PIAS1 through deubiquitination. The USP1/PIAS1/HELLS axis drives EMT and homologous recombination repair in HCC cells.\",\n      \"method\": \"Co-immunoprecipitation (USP1-HELLS), ubiquitination/SUMOylation assays, functional assays in HCC cells, in vivo xenograft, USP1 inhibitor (ML323) treatment\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for interaction, direct biochemical ubiquitination/SUMOylation assays, in vivo validation, single lab\",\n      \"pmids\": [\"41430042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS knockout in human pluripotent stem cells induces a global loss of DNA methylation that is most prominent over peri/centromeric satellite repeats (as defined by the telomere-to-telomere genome assembly), but HELLS appears dispensable for local enhancer remodeling and differentiation into the three embryonic germ layers.\",\n      \"method\": \"HELLS and DNMT3A/B knockout in human pluripotent stem cells, whole-genome bisulfite sequencing, ATAC-seq, differentiation assays\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with genome-wide bisulfite + ATAC-seq, T2T assembly annotation, functional differentiation assays\",\n      \"pmids\": [\"40676590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HELLS alone assembles into a hexameric (trimer-of-dimers) autoinhibited state in its apo form (cryo-EM structure), with the N-terminal coiled-coil (CC) domain stabilizing interactions with ATPase Lobe-1 while Lobe-2 is disengaged. CDCA7 binding and DNA (particularly hemimethylated CpG) promote formation of an active ternary complex and stimulate HELLS ATPase activity.\",\n      \"method\": \"Cryo-EM, ATPase assays, biophysical binding assays (preprint version)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — cryo-EM structure with biochemical validation but preprint; superseded by peer-reviewed version (PMID 41954988)\",\n      \"pmids\": [\"41669160\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ZBTB24, CDCA7 and HELLS function as negative regulators of 2C-like reprogramming in mouse ESCs by maintaining DNA methylation of the Dux cluster. Disruption of HELLS results in Dux hypomethylation and derepression, leading to upregulation of 2C-specific genes. Site-specific re-methylation at the Dux promoter reverses this phenotype. CDCA7 is enriched at the Dux cluster and recruits the CDCA7-HELLS complex to constitutive heterochromatin.\",\n      \"method\": \"CRISPR knockout of ZBTB24/CDCA7/HELLS in mESCs, bisulfite sequencing, ChIP, dCas9-based targeted methylation rescue, single-cell RNA-seq\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with mechanistic rescue by targeted re-methylation, ChIP for complex recruitment, multiple orthogonal approaches\",\n      \"pmids\": [\"40226918\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HELLS is an SNF2-family ATP-dependent chromatin remodeler that, in its apo form, adopts an autoinhibited hexameric architecture; it is activated into a catalytically competent nucleosome remodeling complex upon binding CDCA7, which senses hemimethylated CpG DNA through its zf-4CXXC_R1 domain and recruits HELLS to replication sites, enabling maintenance DNA methylation at heterochromatin and pericentromeric repeats. Beyond DNA methylation maintenance, HELLS participates in multiple DNA repair pathways (homologous recombination via CtIP, classical NHEJ via Ku70/Ku80, and single-strand break repair), regulates meiotic recombination hot spot activation together with PRDM9, controls gene transcription as a co-activator of E2F3 and MYC, suppresses R-loop accumulation to facilitate RNAPII elongation, and can bind and resolve G-quadruplex structures; its loss causes ICF syndrome through combined defects in DNA methylation and DNA repair.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HELLS is an SNF2-family ATP-dependent chromatin remodeling ATPase that maintains DNA methylation at heterochromatin and pericentromeric/satellite repeats and supports multiple genome-stability pathways [#8, #29]. In its apo state HELLS self-assembles into an autoinhibited hexamer (trimer-of-dimers) in which the N-terminal coiled-coil domain serves as both an oligomerization scaffold and an autoinhibitory module engaging ATPase Lobe-1 [#5]. HELLS alone cannot remodel nucleosomes; it is activated by CDCA7, which recognizes hemimethylated CpG DNA through its zf-4CXXC_R1 zinc-finger domain, loads HELLS onto chromatin at replication sites, and stimulates HELLS ATPase and nucleosome-sliding activity to form a catalytically competent ternary remodeling complex [#0, #5, #6, #7]. This CDCA7–HELLS complex enables accumulation of the maintenance methylation machinery (DNMT1/UHRF1) on nascent DNA and is recruited to constitutive heterochromatin to silence repeats such as the Dux cluster; ICF-syndrome zinc-finger mutations in CDCA7 abolish hemimethylated-DNA binding and HELLS recruitment [#7, #10, #31]. ATPase activity is dispensable for heterochromatin recruitment but required for release from pericentromeric sites, a step coupled to H3K9me3 [#11]. Beyond methylation maintenance, HELLS promotes DNA double-strand break repair by facilitating CtIP-dependent end resection in homologous recombination and by interacting with Ku70/Ku80 to support classical NHEJ, including immunoglobulin class-switch recombination, and contributes to single-strand break repair with synthetic-lethal relationships to PARP1 and HR deficiency [#1, #2, #15, #23]. HELLS is also recruited by PRDM9 to meiotic recombination hot spots, where it establishes chromatin accessibility and is required for hot-spot DSB activity and meiotic progression [#3, #4, #13]. As a transcriptional regulator it partners with E2F3 and MYC and binds active promoters to drive proliferative gene programs, and its overexpression in hepatocellular carcinoma remodels nucleosomes to silence tumor-suppressor genes [#9, #16, #19]. HELLS loss causes global DNA hypomethylation with premature aging and senescence phenotypes in mice [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established HELLS/PASG as a proliferation-associated SNF2-family chromatin remodeling ATPase with a defined N-terminal nuclear localization sequence, anchoring it to the SWI/SNF remodeler class.\",\n      \"evidence\": \"cDNA and sequence analysis with deletion mapping of the NLS, expression studies in leukemia samples\",\n      \"pmids\": [\"10910076\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct demonstration of nucleosome remodeling activity\", \"No interacting partners or substrate specificity defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the core in vivo role of HELLS by showing its loss causes global DNA hypomethylation linked to growth retardation, premature aging, and replicative senescence.\",\n      \"evidence\": \"PASG/LSH-null mouse knockout with bisulfite sequencing and primary fibroblast senescence assays\",\n      \"pmids\": [\"15105378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether HELLS acts directly on methylation machinery or via remodeling\", \"Recruitment mechanism to target loci unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected HELLS to oncogenic transcription by showing it interacts with E2F3A and is required for induction of E2F-target genes and cell-cycle re-entry, expanding its role beyond methylation.\",\n      \"evidence\": \"Mass spectrometry, Co-IP, ChIP-seq, and siRNA knockdown with cell-cycle analysis\",\n      \"pmids\": [\"22157815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether transcriptional co-activation requires ATPase/remodeling activity not resolved\", \"Direct vs indirect promoter effects not separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated HELLS is essential for male meiotic progression, foreshadowing a chromatin role at meiotic loci.\",\n      \"evidence\": \"Hells-/- testis allografting with cytological analysis of meiotic synapsis\",\n      \"pmids\": [\"21349825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target loci of HELLS in meiosis not identified\", \"Mechanism of arrest at midpachytene unknown at the time\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Distinguished recruitment from catalysis by showing ATPase activity is not needed for heterochromatin targeting but is required for HELLS release, with H3K9me3 coupling enzymatic turnover to chromatin dynamics.\",\n      \"evidence\": \"ATPase-domain mutagenesis with quantitative FRAP and chromatin fractionation\",\n      \"pmids\": [\"25823553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Factor mediating initial recruitment not identified\", \"Link between release and methylation maintenance not yet mechanistic\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the recruitment problem by identifying CDCA7 as the obligate partner that loads HELLS onto chromatin and reconstitutes nucleosome remodeling, with ICF mutations failing to recruit the complex.\",\n      \"evidence\": \"Xenopus egg extract chromatin proteomics, in vitro remodeling reconstitution, chromatin fractionation, ICF mutant analysis\",\n      \"pmids\": [\"29339483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of HELLS activation by CDCA7 not yet defined\", \"Role of Aurora B sensitivity in regulation unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended HELLS function into genome maintenance by showing HELLS and CDCA7 interact with Ku70/Ku80 and are required for classical NHEJ, with loss producing genome instability.\",\n      \"evidence\": \"Reciprocal Co-IP, knockdown in HEK293, live imaging of Ku80 recruitment, chromosomal break repair assays in patient cells\",\n      \"pmids\": [\"30307408\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether remodeling activity is required for NHEJ support not tested\", \"Direct vs scaffolding role at break sites unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed HELLS also promotes homologous recombination by facilitating CtIP-dependent end resection, requiring its ATPase domain, especially in heterochromatic DSB repair.\",\n      \"evidence\": \"Co-IP with CtIP, IR-induced foci immunofluorescence, ATPase mutant analysis, cell-cycle staged assays\",\n      \"pmids\": [\"31802118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HELLS choice between HR and NHEJ pathways is regulated unknown\", \"Mechanism linking remodeling to resection not detailed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined HELLS as a PRDM9 pioneer-complex partner required for chromatin accessibility, histone modification, and DSB targeting at meiotic recombination hot spots.\",\n      \"evidence\": \"Mouse knockout, proteomic identification of PRDM9 partners, ChIP-seq, ATAC-seq, 5hmC and DSB mapping\",\n      \"pmids\": [\"32001511\", \"33047671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PRDM9 directs HELLS independently of CDCA7-hemimethyl recognition unclear\", \"Relationship between hot-spot 5hmC and DSB formation not fully mechanistic\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked HELLS-CDCA7 remodeling to maintenance methylation machinery loading and to suppression of pericentromeric R-loop-associated damage.\",\n      \"evidence\": \"Nascent-DNA proteomics, R-loop detection, RNASEH1 rescue, bisulfite sequencing\",\n      \"pmids\": [\"33082427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab; direct causality between R-loop suppression and methylation maintenance not separated\", \"No structural mechanism for DNMT1/UHRF1 recruitment\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated HELLS supports classical NHEJ during immunoglobulin class-switch recombination, with the defect downstream of break initiation.\",\n      \"evidence\": \"Conditional Lsh knockout B cells, End-seq, digestion-circularization PCR, high-throughput CSR junction sequencing\",\n      \"pmids\": [\"32727902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the CSR defect reflects methylation maintenance or direct end-joining support not fully separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a centromeric integrity role in oocyte meiosis, with LSH at kinetochores retaining HDAC2/DNMT1 and restraining satellite transcription.\",\n      \"evidence\": \"Oocyte-specific conditional knockout, super-resolution microscopy, immunofluorescence, chromosome spreads\",\n      \"pmids\": [\"32900989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism of kinetochore targeting unknown\", \"Relationship to CDCA7-dependent recruitment not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Implicated HELLS in 5hmC homeostasis through TET interaction, with effects not fully explained by 5mC loss.\",\n      \"evidence\": \"Co-IP with TET, Lsh knockout cells, genome-wide oxBS 5hmC sequencing\",\n      \"pmids\": [\"33960278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; whether HELLS directly facilitates TET activity not established\", \"Functional consequence of 5hmC redistribution unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the structural mechanism of targeting by showing CDCA7's zf-4CXXC_R1 domain selectively reads hemimethylated CpG in linker DNA and recruits HELLS, with ICF mutations abolishing this.\",\n      \"evidence\": \"Cryo-EM of CDCA7-nucleosome complex, in vitro DNA binding, ICF mutant analysis (preprint)\",\n      \"pmids\": [\"38187757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Preprint at time of capture\", \"How recognition couples to HELLS catalytic activation not fully resolved here\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Mapped CDCA7 domains controlling HELLS binding and activation, showing the central region activates ATPase/sliding while the C-terminal zinc finger confers hemimethyl-CpG preference.\",\n      \"evidence\": \"In vitro ATPase and nucleosome sliding assays with CDCA7 domain mutants, DNA binding, mES cell immunofluorescence\",\n      \"pmids\": [\"39142653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational changes in HELLS upon activation not visualized in this study\", \"Regulation of CDCA7 autoinhibition in vivo unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Solved the autoinhibited HELLS hexamer by cryo-EM, revealing the coiled-coil domain as both oligomerization scaffold and autoinhibitory module released upon CDCA7/DNA binding to form an active ternary complex.\",\n      \"evidence\": \"Cryo-EM structure with ATPase and biophysical binding assays (peer-reviewed and preprint versions)\",\n      \"pmids\": [\"41954988\", \"41669160\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the fully engaged remodeling complex on a nucleosome not resolved\", \"How oligomeric state changes during catalysis unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established HELLS as a single-strand break repair factor with synthetic-lethal vulnerabilities, compensating for PARP1 and sensitizing HR-deficient cells.\",\n      \"evidence\": \"HELLS knockout/knockdown, SSB repair assays, alkylator/PARPi sensitivity, PARP1 epistasis\",\n      \"pmids\": [\"41297801\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of HELLS in SSBR not defined\", \"Single lab; direct enzymatic role versus chromatin context not separated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Refined the methylation-maintenance role by showing HELLS-dependent methylation is concentrated at peri/centromeric satellites yet dispensable for enhancer remodeling and germ-layer differentiation.\",\n      \"evidence\": \"HELLS and DNMT3A/B knockouts in human pluripotent stem cells, whole-genome bisulfite, ATAC-seq, differentiation assays with T2T annotation\",\n      \"pmids\": [\"40676590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why some loci are HELLS-independent not mechanistically explained\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed the ZBTB24-CDCA7-HELLS axis silences the Dux cluster to restrain 2C-like reprogramming, with targeted re-methylation rescuing the phenotype.\",\n      \"evidence\": \"CRISPR knockouts in mESCs, bisulfite sequencing, ChIP, dCas9-targeted methylation rescue, scRNA-seq\",\n      \"pmids\": [\"40226918\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ZBTB24 integrates with CDCA7-hemimethyl recognition not detailed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified HELLS as a G-quadruplex binding and unwinding protein that modulates gene expression, adding a structured-DNA resolution activity.\",\n      \"evidence\": \"Photoclick proteomics, fluorescence anisotropy, FRET unwinding assays, ChIP-seq\",\n      \"pmids\": [\"41569154\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; relationship of G4 resolution to remodeling/methylation roles unclear\", \"In vivo physiological significance not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected HELLS chromatin function to broader transcriptional and metabolic outputs in cancer through R-loop suppression and direct target gene regulation.\",\n      \"evidence\": \"Multi-omics ChIP/DRIP/RNA-seq, RNAPII ChIP-seq, ChIP-qPCR/FAIRE, mitochondrial assays, and stability regulation via USP1 in HCC/ALCL contexts\",\n      \"pmids\": [\"38597676\", \"33504766\", \"30779712\", \"30516846\", \"40175344\", \"41947194\", \"41430042\", \"28442710\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Many context-specific targets from single labs\", \"Whether effects depend on remodeling versus scaffolding not consistently tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HELLS partitions among its many roles — maintenance methylation, HR/NHEJ/SSB repair, meiotic hot-spot priming, G4 resolution, and transcriptional regulation — and how the CDCA7-dependent activation switch is selectively deployed at each remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model coordinating recruitment cues across pathways\", \"Structure of the active HELLS-CDCA7 complex engaged on a nucleosome unresolved\", \"Whether non-methylation roles require the same activation mechanism unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 5, 7, 11]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 27]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9, 16, 19, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [11, 14, 29, 31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 8, 29, 31]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 2, 15, 23]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [3, 4, 13, 14]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 16, 21]}\n    ],\n    \"complexes\": [\n      \"HELLS-CDCA7 nucleosome remodeling complex\",\n      \"PRDM9 meiotic pioneer complex\"\n    ],\n    \"partners\": [\n      \"CDCA7\",\n      \"PRDM9\",\n      \"CtIP\",\n      \"Ku70\",\n      \"Ku80\",\n      \"E2F3\",\n      \"MYC\",\n      \"TET\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}